US 9102938
2′ and 5′ modified monomers and oligonucleotides
granted A61KA61K48/00
Quick answer
US patent 9102938 (2′ and 5′ modified monomers and oligonucleotides) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K48/00